Favorable short‐term outcomes of micronized allogenic cartilage scaffold for glenoid cartilage defects associated with posterior glenohumeral instability
Arthroscopy, Sports Medicine, and Rehabilitation · 2023-12 · 5 (6)
DOI: 10.1016/j.asmr.2023.100809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthroscopy, Sports Medicine, and Rehabilitation, online erschienen am 15.10.2023. Verfasst von Michael D Bedrin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, U.S.A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To determine clinical outcomes associated with micronized allogenic cartilage scaffold use for treatment of posterior glenoid cartilage defects at 2 years.
Methods
A retrospective analysis of prospectively collected data was performed on a consecutive series of patients who underwent arthroscopic treatment of a symptomatic posterior glenoid cartilage defect with micronized allogenic cartilage scaffold between January 2019 and December 2020. The primary outcome was subjective shoulder value (SSV) at latest follow‐up. Secondary outcomes included visual analog scale (VAS), recurrence of instability, and range of motion (ROM).
Results
Seven patients, including 4 in the setting of primary posterior instability and 3 in the setting of recurrent symptoms after arthroscopic posterior glenohumeral stabilization, were included in the analysis with a mean follow up of 2.6 years (range, 2‐3.7 years). Statistically significant improvements were seen in SSV (median = 40, interquartile range [IQR] = 40‐50 before surgery; vs median = 85, IQR = 67.5‐87.5 after surgery; P = .018) and VAS (median = 4, IQR = 4‐6.3 before surgery; vs median = 1, IQR = 0‐1.5 after surgery; P = .010). No significant differences were seen in ROM. There were no cases of recurrent instability or reoperation.
Conclusions
The use of micronized allogenic cartilage scaffold for glenoid cartilage defects is associated with clinical improvement at 2‐year follow‐up. This is the case when performed in conjunction with index posterior labral repair when there is a concomitant glenoid cartilage defect or when performed in the setting of persistent pain and mechanical symptoms after prior posterior labral repair. Level of Evidence Level IV, therapeutic case series.
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, U.S.A.
- Uniformed Services University of Health Sciences, Bethesda, Maryland, U.S.A.
- Duke University, Department of Orthopaedics, Durham, North Carolina, U.S.A.
- Department of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Zitieren
APA
Bedrin, M. D., Clark, D. M., Yow, B. G., Dickens, J. F., & Kilcoyne, K. G. (2023). Favorable short‐term outcomes of micronized allogenic cartilage scaffold for glenoid cartilage defects associated with posterior glenohumeral instability. Arthroscopy, Sports Medicine, and Rehabilitation, 5(6). https://doi.org/10.1016/j.asmr.2023.100809
Vancouver
Bedrin MD, Clark DM, Yow BG, Dickens JF, Kilcoyne KG. Favorable short‐term outcomes of micronized allogenic cartilage scaffold for glenoid cartilage defects associated with posterior glenohumeral instability. Arthroscopy, Sports Medicine, and Rehabilitation. 2023;5(6). doi:10.1016/j.asmr.2023.100809
BibTeX
@article{Bedrin2023,
author = {Bedrin, Michael D and Clark, DesRaj M and Yow, Bobby G and Dickens, Jonathan F and Kilcoyne, Kelly G},
title = {Favorable short‐term outcomes of micronized allogenic cartilage scaffold for glenoid cartilage defects associated with posterior glenohumeral instability},
journal = {Arthroscopy, Sports Medicine, and Rehabilitation},
year = {2023},
volume = {5},
number = {6},
doi = {10.1016/j.asmr.2023.100809}
}
EUVIMED